Citigroup Inc Johnson & Johnson Transaction History

Citigroup Inc

$150 Billion
Q1 2024

A detailed history of Citigroup Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Citigroup Inc holds 2,472,910 shares of JNJ stock, worth $361 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

2,472,910

Previous 2,136,327 15.76%

Holding current value

$361 Million

Previous $335 Million 16.83%

% of portfolio

0.26%

Previous 0.24%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$155.22 - $162.74 $52.2 Million - $54.8 Million	336,583 Added 15.76%	2,472,910 $391 Million
Q4 2023 Feb 09, 2024	SELL	$145.6 - $158.88 $5.74 Million - $6.26 Million	-39,394 Reduced 1.81%	2,136,327 $335 Million
Q3 2023 Nov 09, 2023	BUY	$155.75 - $174.48 $29.4 Million - $32.9 Million	188,728 Added 9.5%	2,175,721 $339 Million
Q2 2023 Aug 10, 2023	SELL	$154.35 - $166.11 $48.8 Million - $52.6 Million	-316,405 Reduced 13.74%	1,986,993 $329 Million
Q1 2023 May 11, 2023	BUY	$151.05 - $180.26 $22.5 Million - $26.9 Million	148,962 Added 6.91%	2,303,398 $357 Million

Q4 2022 Feb 09, 2023	SELL	$160.2 - $179.79 $10.4 Million - $11.7 Million	-64,956 Reduced 2.93%	2,154,436 $381 Million
Q3 2022 Nov 10, 2022	BUY	$161.33 - $179.52 $32.1 Million - $35.7 Million	198,774 Added 9.84%	2,219,392 $363 Million
Q2 2022 Aug 10, 2022	SELL	$168.19 - $186.01 $1.97 Million - $2.18 Million	-11,697 Reduced 0.58%	2,020,618 $359 Million
Q1 2022 May 12, 2022	SELL	$158.14 - $179.59 $79.3 Million - $90.1 Million	-501,440 Reduced 19.79%	2,032,315 $360 Million
Q4 2021 Feb 10, 2022	SELL	$155.93 - $173.01 $43.2 Million - $47.9 Million	-277,149 Reduced 9.86%	2,533,755 $433 Million
Q3 2021 Nov 10, 2021	BUY	$161.5 - $179.47 $454 Million - $504 Million	2,810,904 New	2,810,904 $454 Million

Others Institutions Holding JNJ

# of Institutions

4,145

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $382B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account